MADRIGAL PHARMACEUTICALS, INC. (MDGL) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
On November14, 2016, Madrigal Pharmaceuticals,Inc. (the Company)
issued a press release announcing its financial results for the
third fiscal quarter ended September30, 2016. A copy of the
Companys press release is furnished with this report as
Exhibit99.1.
In accordance with General Instruction B.2 of Form8-K, the
information in this Item 2.02 and Exhibit99.1 of this Current
Report on Form8-K are being furnished and shall not be deemed to
be filed for purposes of Section18 of the Securities Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of
that Section. Furthermore, such information, including
Exhibit99.1 attached hereto, shall not be deemed to be
incorporated by reference in any filing under the Securities Act
of 1933, as amended, except as expressly stated by specific
reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
ExhibitNo. |
|
Description |
|
99.1 |
Press Release issued November14, 2016 |
About MADRIGAL PHARMACEUTICALS, INC. (MDGL)
